Craig C. Hofmeister

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)”.

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Leukemia(2020)10.1038/s41375-020-0718-z

N/A

2.9DataRank · unranked

98 citations

Ajai Chari, Yaël C. Cohen, Andrew Spencer, Peter M. Voorhees, Jane Estell +16 more

Initial genome sequencing and analysis of multiple myeloma

Nature(2011)10.1038/nature09837

N/A

1.1DataRank · unranked

1438 citations

Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis, Carrie Sougnez, Anna C. Schinzel +51 more

Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2931

N/A

0.730DataRank · unranked

20 citations

Vikas A. Gupta, Shannon M. Matulis, Jonathan C. Patton, Doris R. Powell, Yanyan Gu +10 more

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

Journal of Clinical Investigation(2023)10.1172/jci167629

N/A

0.581DataRank · unranked

47 citations

Nancy Villa, David L. Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel S. McCachren +19 more

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

Laryngoscope Investigative Otolaryngology(2021)10.1002/lio2.643

N/A

0.546DataRank · unranked

37 citations

Katharine A. Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu, Beth A. Miles‐Markley +10 more

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0043

N/A

0.538DataRank · unranked

35 citations

Ajay K. Nooka, Allison R. Carr, Katherine E. Pendleton, Benjamin G. Barwick, Renee Julia Manalo +12 more

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Leukemia(2022)10.1038/s41375-022-01691-1

N/A

0.416DataRank · unranked

15 citations

Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao +10 more

Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects

Journal of Hematology & Oncology(2025)10.1186/s13045-024-01645-3

N/A

0.397DataRank · unranked

9 citations

Theophilus Tandoh, Lokesh Nigam, Mahmoud Singer, Enrico Caserta, Mariam Murtadha +16 more

Venetoclax ex vivo functional profiling predicts improved progression-free survival

Blood Cancer Journal(2022)10.1038/s41408-022-00710-9

N/A

0.345DataRank · unranked

9 citations

Shannon M. Matulis, Benjamin G. Barwick, R. Devin Bog, Conrad W. Shebelut, Mala Shanmugam +12 more

Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.09.024

N/A

0.345DataRank · unranked

9 citations

Vikas A. Gupta, Sarah Wyman, Michael Graiser, Jonathan L. Kaufman, Dhwani Almaula +7 more

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

npj Vaccines(2024)10.1038/s41541-024-00999-6

N/A

0.165DataRank · unranked

2 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

Association ofANRILPolymorphism With Overall Survival in Adult Patients With Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation

Anticancer Research(2020)10.21873/anticanres.14585

N/A

0DataRank · unranked

7 citations

Nathan D. Seligson, Xuejie Zhang, Jasmine A. Johnson, Zachary VanGundy, Daqing Wang +5 more

Proteasome inhibition enhances myeloma oncolytic reovirus therapy by suppressing monocytic anti-viral immune responses

medRxiv(2022)10.1101/2022.03.29.22272857

N/A

0DataRank · unranked

1 citations

Enrico Caserta, Mahmoud Singer, Theophilus Tandoh, Lokesh Nigam, Janet Winchester +14 more

1458 Regulation of neoantigen specific T cell infiltration and spatial tumor immune architecture of myeloma and its premalignant precursors

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1458

N/A

0DataRank · unranked

0 citations

Hope Robinson, David L. Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel S. McCachren +16 more

Oncolytic virus pelareorep plus carfilzomib phase I trial in carfilzomib-refractory patients (NCI 9603): Responses with cytokine storm.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8535

N/A

0DataRank · unranked

1 citations

Domenico Viola, Ada Donà, Ajay K. Nooka, Jonathan L. Kaufman, Sagar Lonial +6 more

Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction

JCO Oncology Practice(2023)10.1200/op.22.00781

N/A

0DataRank · unranked

12 citations

Kathryn T. Maples, Kevin Hall, Yuan Liu, Yichun Cao, Nisha S. Joseph +7 more

Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

(2023)10.1158/2643-3230.c.6551220

N/A

0DataRank · unranked

0 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.17.553767

N/A

0DataRank · unranked

0 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

Research Square(2023)10.21203/rs.3.rs-3293339/v1

N/A

0DataRank · unranked

0 citations

Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis +10 more

CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation

Frontiers in Pharmacology(2024)10.3389/fphar.2023.1334440

N/A

0DataRank · unranked

8 citations

Xunjie Zhang, Mark Zemanek, Jasmine A. Johnson, Zachary VanGundy, Daqing Wang +6 more

Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy

Journal of Clinical Investigation(2025)10.1172/jci192927

N/A

0DataRank · unranked

9 citations

Anshika Goenka, Maryam I. Azeem, Azmain Taz, Sayalee Potdar, Sara A. Scott +10 more

Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

Leukemia(2020)10.1038/s41375-020-0810-4

N/A

0DataRank · unranked

89 citations

Ada Donà, Enrico Caserta, Estelle Troadec, Francesca Besi, Tinisha McDonald +23 more

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.02.009

N/A

0DataRank · unranked

10 citations

Ada Donà, Mariam Murtadha, Emine Gulsen Gunes, Enrico Caserta, Ji Young Yoo +12 more

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Journal of Clinical Oncology(2022)10.1200/jco.21.02257

N/A

0DataRank · unranked

49 citations

Uma Shanmugasundaram, Narayanaiah Cheedarla, Hans Verkerke, Venkata Viswanadh Edara, Rajesh M. Valanparambil +16 more

Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0173

N/A

0DataRank · unranked

33 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more